Home Tags Trop-2-directed antibody

Tag: Trop-2-directed antibody

ESMO 2020: In Heavily-pretreated Metastatic Urothelial Cancer Sacituzumab Govitecan Shows 27%...

Heavily-pretreated, cisplatin-eligible, patients benefit from treatment with sacituzumab govitecan (sacituzumab govitecan-hziy; Trodelvy®; Immunimedics).This is the conclusion from an analysis of data from the pivotal...